35150008: Glucocorticoid hormone (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

58652012 Glucocorticoid hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

766757010 Glucocorticoid hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3486691000005112 glucocorticoidhormon da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
glucocorticoidhormon	Is a	Corticosteroid and/or corticosteroid derivative	false	Inferred relationship	Some
glucocorticoidhormon	Is a	Adrenal cortex hormone	false	Inferred relationship	Some
glucocorticoidhormon	Is a	Steroid hormone	false	Inferred relationship	Some
glucocorticoidhormon	Is a	Glucocorticoid (substance)	false	Inferred relationship	Some
glucocorticoidhormon	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Adrenal cortex hormone (disposition)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethason 1 mg + neomycinsulfat 3,5 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethason 1 mg + tobramycin 3 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
gentamicinsulfat 0,3 % wt/wt + prednisolonacetat 0,6 % wt/wt salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
gentamicinsulfat + prednisolonacetat 0,3 %/1 % vol/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat 0,35 %/10.000 enheder/0,5 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
nystatin 100.000 enheder + triamcinolonacetonid 1 mg creme	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
nystatin 100.000 enheder + triamcinolonacetonid 1 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
nystatin 10.000 enheder + triamcinolonacetonid 1 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat + sulfacetamidnatrium 0,2 % wt/vol/10 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat + sulfacetamidnatrium 0,25 % wt/vol/10 % wt/vol suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat 5 mg + sulfacetamidnatrium 100 mg salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat 5 mg + sulfacetamidnatrium 100 mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonnatriumphosphat 2,5 mg + sulfacetamidnatrium 100 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing betamethasone and calcipotriol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisolone 3 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat 0,5 %, øjendråber til engangsbrug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing betamethasone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat 24 mg injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat 4 mg injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat 10 mg injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
gentamicinsulfat + prednisolonacetat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethason + neomycinsulfat + polymyxin B-sulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
dexamethasonnatriumphosphat +neomycinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
betamethasondinatriumphosphat 3 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
betamethasondinatriumphosphat 4 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
triamcinolonhexacetonid 20 mg/ml injektionsvæske, suspension, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat 0,5 % wt/wt + sulfacetamidnatrium 10 % wt/wt salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone hexacetonide 5mg/mL injection suspension 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 30 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
prednisolonnatriumphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Prednisolone 20mg/100mL enema	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone 40mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone 80mg/2mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing desoximetasone and salicylic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing betamethasone and clioquinol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Desonide 500 microgram/mL cutaneous foam	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Desonide 500 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone acetonide 250 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone acetonide 1 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone acetonide 1 mg/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
Triamcinolone acetonide 1 mg/mL cutaneous lotion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	glucocorticoidhormon	Inferred relationship	Some
17-ketogenic steroid (substance)	Is a	False	glucocorticoidhormon	Inferred relationship	Some
Medrysone (substance)	Is a	False	glucocorticoidhormon	Inferred relationship	Some
Tetrahydrocorticosterone	Is a	False	glucocorticoidhormon	Inferred relationship	Some

Start Previous Page 5 of 5

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
58652012	Glucocorticoid hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
766757010	Glucocorticoid hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3486691000005112	glucocorticoidhormon	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)